Skip to content
TrialScanner

NCT02307487

Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients

Phase 2CompletedURGNLead

Registry record

Lead sponsor
UroGen Pharma Ltd.
Conditions
Bladder Cancer; Neoplasms; Urinary Bladder Diseases; Urologic Diseases
Primary completion
Apr 2016Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02307487 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02307487: Safety of Pre-TURBT Intravesi... | TrialScanner